Table 1 Characteristics of patients, GBM specimens, and corresponding neurospheres.

BT, brain tumor; MES, mesenchymal; PN, proneural; CLAS, classical; ND, not determined; Unmet, unmethylated; Met, methylated; OS, overall survival; F, female; M, male.

GBMCSPG4 expression% CSPG4
GBM-NS
OSSubtypeMGMT
methylation
AgeGender
SpecimensVessels
BT168+++++49.06.0MESUnmet78F
BT205++85.02.0PNUnmet73M
BT423++++98.76.5CLASMet43F
BT273++/−85.914.0CLASMet59M
BT275+++97.415.0CLASMet67F
BT299+++99.06.5PNUnmet50M
BT308+++96.03.0PNUnmet76M
BT326+++63.06.5PNUnmet28M
BT328++/−83.26.0MESUnmet56M
BT358++++95.622.0MESUnmet64F
BT373++++55.43.0PNUnmet65M
BT417+++90.011.0CLASMet53M
BT462+++42.510.0CLASUnmet71M
BT482+++82.68.0MESUnmet38M
BT517++++91.98.0CLASUnmet48M
BT137+++6.0PNUnmet37F
BT140+++10.0MESUnmet47F
BT150+++10.0CLASUnmet61M
BT157++/−9.0MESUnmet54M
BT202+++4.0MESUnmet70M
BT206+++4.5CLASUnmet69M
BT211+++4.5MESND61M
BT209+++4.5PNUnmet56M
BT219++5.0MESUnmet55M
BT235++++24.5CLASMet70M
BT261++++3.0CLASUnmet65M
BT334++++9.0CLASUnmet63M
BT513+++13.0MESUnmet58M
BT241+++13.0NDUnmet70M
BT248+++6.0NDMet64M
BT347++++29.0NDMet57F
BT302+/−++16.060.0MESUnmet19F
BT337+/−++69.017.5PNMet65M
BT379+/−++97.016.0CLASUnmet73M
BT422+/−+/−59.136.0CLASUnmet70M
BT480+/−++59.013.0MESUnmet69F
BT483+/−++97.715.0PNMet54M
BT487+/−++70.624.0MESUnmet72M
BT500+/−++84.09.5CLASUnmet67F
BT155+/−++13.0CLASUnmet46F
BT245+/−++46.0PNMet57F
BT274+18.0PNUnmet50M
BT279+/−+15.0CLASUnmet60F
BT283+/−+9.5CLASMet46F
BT490+/−++16.0PNUnmet76F
BT175+/−+12.5NDUnmet63M